---
title: "Gut microbial structural variation enhances RA discrimination and reveals a strain-level regulator"
id: "medrxiv-13-gut-microbial-structural-variation-improves-disease-discrimination-and-reveals"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-13-gut-microbial-structural-variation-improves-disease-discrimination-and-reveals"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.23.26358822v1?rss=1"
published_at: "2026-07-27T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Gut microbial structural variation enhances RA discrimination and reveals a strain-level regulator
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-13-gut-microbial-structural-variation-improves-disease-discrimination-and-reveals
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.23.26358822v1?rss=1)
- **Published At:** 2026-07-27T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study integrated gut whole-genome shotgun metagenomic datasets from four independent cohorts totaling **n = 491** participants to investigate the role of microbial **structural variation** (SV) in rheumatoid arthritis (RA). - Researchers identified reproducible RA-associated SVs across cohorts; most of these SVs occurred in species that did not show differences in overall abundance between RA and control groups. - Incorporating SV features into machine-learning classifiers improved disease discrimination consistently across independent validation cohorts compared with models using species abundance alone. - Functional follow-up identified a core deletion SV in **Agathobacter rectalis** that removes an XRE-family transcriptional regulator gene. - Motif discovery and 3D structural modeling indicated sequence-specific binding of the deleted regulator to the promoter of a **short-chain fatty acid** (SCFA) biosynthetic gene, supporting a strain-level regulatory mechanism linking SV to microbial function. - The findings position microbial SV as a complementary, strain-resolving functional layer beyond traditional taxonomy for both diagnostic discrimination and mechanistic inference in RA. - Whole-genome shotgun sequencing data are deposited in public archives (GSA accession CRA004348 and PRJCA000337; EBI accession PRJEB6997). - The paper is a medRxiv preprint and has not been peer reviewed; authors declare no competing interests and report appropriate ethical approvals and participant consent. - Details such as cohort clinical characteristics, exact machine-learning algorithms, classifier performance metrics, and sample-level statistics were not reported in the provided source excerpt and therefore are not described here.
## Clinical Analysis & Structured Key Points
Gut microbial structural variation improves disease discrimination and reveals a strain-level regulatory mechanism in rheumatoid arthritis | medRxiv Skip to main content Gut microbial structural variation improves disease discrimination and reveals a strain-level regulatory mechanism in rheumatoid arthritis Yang Ou MD., PhD , Shengyan Zhao PhD , Jiachun Weng MD , Yichen Long MD., PhD , Huamei Li PhD , Yue Hou MD., PhD , Qing Xiong PhD , Sha Liu MD., PhD , Zhikang Wang MD , Yuhui Xu MD., PhD , Hui Pan MD., PhD , Huayong Zhang MD., PhD , Lingyun Sun MD., PhD doi: https://doi.org/10.64898/2026.07.23.26358822 Yang Ou MD., PhD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Shengyan Zhao PhD 2 Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jiachun Weng MD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yichen Long MD., PhD 3 Centre for Quantitative Medicine, Duke-NUS Medical School, National University of Singapore, Singapore, Singapore; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Huamei Li PhD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yue Hou MD., PhD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Qing Xiong PhD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sha Liu MD., PhD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Zhikang Wang MD 1 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yuhui Xu MD., PhD 4 Department of Obstetrics and Gynecology, State Key Laboratory of Common Mechanism Research for Major Diseases, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Scienc; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hui Pan MD., PhD 5 Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Huayong Zhang MD., PhD 6 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: huayong.zhang{at}nju.edu.cn Lingyun Sun MD., PhD 6 Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Gut microbial structural variation captures strain-level genomic diversity beyond species abundance, yet its contribution to rheumatoid arthritis (RA) remains unclear. Integrating gut metagenomic datasets from four independent cohorts (n = 491), we identified reproducible RA-associated structural variants (SVs), most of which occurred in species without differential abundance. Incorporating SVs into machine learning models consistently improved disease discrimination across independent validation cohorts. Functional analyses identified a core deletion SV in Agathobacter rectalis that removes an XRE-family transcriptional regulator. Motif discovery and 3D structural modeling demonstrated sequence-specific binding of the regulator to the promoter of a short-chain fatty acid biosynthetic gene, supporting a strain-level regulatory mechanism. Together, these findings establish microbial structural variation as a complementary functional layer beyond taxonomy for RA discrimination and mechanistic interpretation. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Whole-genome shotgun sequencing data have been deposited in the Genome Sequence Archive (GSA) at the National Genomics Data Center (accession numbers CRA004348 and PRJCA000337) and the European Bioinformatics Institute (EBI) database (accession number PRJEB6997). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Whole-genome shotgun sequencing data have been deposited in the Genome Sequence Archive (GSA) at the National Genomics Data Center (accession numbers CRA004348 and PRJCA000337) and the European Bioinformatics Institute (EBI) database (accession number PRJEB6997). Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted July 27, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Gut microbial structural variation improves disease discrimination and reveals a strain-level regulatory mechanism in rheumatoid arthritis Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Gut microbial structural variation improves disease discrimination and reveals a strain-level regulatory mechanism in rheumatoid arthritis Yang Ou MD., PhD , Shengyan Zhao PhD , Jiachun Weng MD , Yichen Long MD., PhD , Huamei Li PhD , Yue Hou MD., PhD , Qing Xiong PhD , Sha Liu MD., PhD , Zhikang Wang MD , Yuhui Xu MD., PhD , Hui Pan MD., PhD , Huayong Zhang MD., PhD , Lingyun Sun MD., PhD medRxiv 2026.07.23.26358822; doi: https://doi.org/10.64898/2026.07.23.26358822 Share This Article: Copy Citation Tools Gut microbial structural variation improves disease discrimination and reveals a strain-level regulatory mechanism in rheumatoid arthritis Yang Ou MD., PhD , Shengyan Zhao PhD , Jiachun Weng MD , Yichen Long MD., PhD , Huamei Li PhD , Yue Hou MD., PhD , Qing Xiong PhD , Sha Liu MD., PhD , Zhikang Wang MD , Yuhui Xu MD., PhD , Hui Pan MD., PhD , Huayong Zhang MD., PhD , Lingyun Sun MD., PhD medRxiv 2026.07.23.26358822; doi: https://doi.org/10.64898/2026.07.23.26358822 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (592) Allergy and Immunology (883) Anesthesia (321) Cardiovascular Medicine (4655) Dentistry and Oral Medicine (465) Dermatology (400) Emergency Medicine (629) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1582) Epidemiology (15601) Forensic Medicine (32) Gastroenterology (1167) Genetic and Genomic Medicine (6859) Geriatric Medicine (708) Health Economics (1029) Health Informatics (4826) Health Policy (1407) Health Systems and Quality Improvement (1686) Hematology (567) HIV/AIDS (1298) Infectious Diseases (except HIV/AIDS) (16129) Intensive Care and Critical Care Medicine (1138) Medical Education (647) Medical Ethics (148) Nephrology (702) Neurology (6990) Nursing (357) Nutrition (1053) Obstetrics and Gynecology (1202) Occupational and Environmental Health (985) Oncology (3492) Ophthalmology (1011) Orthopedics (381) Otolaryngology (431) Pain Medicine (452) Palliative Medicine (135) Pathology (691) Pediatrics (1747) Pharmacology and Therapeutics (720) Primary Care Research (747) Psychiatry and Clinical Psychology (5698) Public and Global Health (9514) Radiology and Imaging (2314) Rehabilitation Medicine and Physical Therapy (1402) Respiratory Medicine (1225) Rheumatology (620) Sexual and Reproductive Health (751) Sports Medicine (564) Surgery (748) Toxicology (105) Transplantation (296) Urology (276)
## Related Clinical Research

- [Brief-COPE Questionnaire Shows Five-Factor Structure in Seropositive Rheumatoid Arthritis](https://medichelpline.com/clinical-feed/medrxiv-1-validation-of-the-brief-cope-questionnaire-in-a-seropositive-rheumatoid.md)
- [Climate change worsens health for people with chronic illness](https://medichelpline.com/clinical-feed/stat-news-1-opinion-climate-change-is-making-people-with-chronic-illness-even-sicker.md)
- [Resveratrol as an Adjunct to DMARDs in Long-Standing Rheumatoid Arthritis: Effects on Low-Grade In](https://medichelpline.com/clinical-feed/medrxiv-12-complementary-use-of-resveratrol-improves-low-grade-chronic-inflammation.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)
- [Semaglutide and Primary Prevention of MACCE in Obese Adults with T2DM and Rheumatoid Arthritis](https://medichelpline.com/clinical-feed/pubmed-42334436.md) (DOI: 10.1093/ehjcvp/pvag044)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.